实用临床医学
實用臨床醫學
실용림상의학
Practical Clinical Medicine
2015年
4期
56-59
,共4页
顾剑华%金晓群%徐艳娜%桂丽琼%李永莲%金殊
顧劍華%金曉群%徐豔娜%桂麗瓊%李永蓮%金殊
고검화%금효군%서염나%계려경%리영련%금수
呼出气一氧化氮%哮喘%哮喘管理%儿童
呼齣氣一氧化氮%哮喘%哮喘管理%兒童
호출기일양화담%효천%효천관리%인동
fractional exhaled nitric oxide%asthma%management of asthma%children
目的:探讨哮喘患儿呼出气一氧化氮(fractional exhaled nitric oxide,FeNO)在儿童哮喘管理中的作用。方法选取未规范治疗的哮喘患儿60例(哮喘组)和同期40例健康儿童(对照组)。哮喘组患儿给予6个月的沙美特罗氟替卡松气雾剂(Shah Mette Lo fluticasone propionate aerosol,商品名:舒利迭,50μg/100μg,bid)治疗,检测治疗前及治疗后6个月的 FeNO、血清嗜酸阳离子蛋白(eosinophile cationic protein,ECP)、血清总免疫球蛋白 E (total serum immunoglobulin E,IgE)及肺功能指标 FEVl占预计值百分比(FEVl%)。结果治疗前,哮喘组 Fe-NO、ECP及 IgE均明显高于对照组(均P<0.01),FEVl%明显低于对照组(P<0.01)。与治疗前比较:哮喘组治疗6个月后的 FeNO、ECP及 IgE显著降低(均P<0.01),但仍高于对照组(均P<0.01);FEVl%水平明显升高(P<0.01),但与对照组比较差异无统计学意义(P>0.05)。治疗前哮喘组 FeNO与血清 ECP、IgE呈正相关(r=0.850,P=0.000;r=0.689,P=0.000),与 FEVl%无相关性(r=-0.216,P=0.097)。治疗6个月后,FeNO仍与血清 ECP呈正相关(r=0.665,P=0.000),而与 FEVl%、IgE 无相关性(r=0.185,r=0.226;P>0.05)。结论FeNO是一种较理想的反映气道嗜酸性炎症的生物学指标,有助于评估哮喘的控制情况。
目的:探討哮喘患兒呼齣氣一氧化氮(fractional exhaled nitric oxide,FeNO)在兒童哮喘管理中的作用。方法選取未規範治療的哮喘患兒60例(哮喘組)和同期40例健康兒童(對照組)。哮喘組患兒給予6箇月的沙美特囉氟替卡鬆氣霧劑(Shah Mette Lo fluticasone propionate aerosol,商品名:舒利迭,50μg/100μg,bid)治療,檢測治療前及治療後6箇月的 FeNO、血清嗜痠暘離子蛋白(eosinophile cationic protein,ECP)、血清總免疫毬蛋白 E (total serum immunoglobulin E,IgE)及肺功能指標 FEVl佔預計值百分比(FEVl%)。結果治療前,哮喘組 Fe-NO、ECP及 IgE均明顯高于對照組(均P<0.01),FEVl%明顯低于對照組(P<0.01)。與治療前比較:哮喘組治療6箇月後的 FeNO、ECP及 IgE顯著降低(均P<0.01),但仍高于對照組(均P<0.01);FEVl%水平明顯升高(P<0.01),但與對照組比較差異無統計學意義(P>0.05)。治療前哮喘組 FeNO與血清 ECP、IgE呈正相關(r=0.850,P=0.000;r=0.689,P=0.000),與 FEVl%無相關性(r=-0.216,P=0.097)。治療6箇月後,FeNO仍與血清 ECP呈正相關(r=0.665,P=0.000),而與 FEVl%、IgE 無相關性(r=0.185,r=0.226;P>0.05)。結論FeNO是一種較理想的反映氣道嗜痠性炎癥的生物學指標,有助于評估哮喘的控製情況。
목적:탐토효천환인호출기일양화담(fractional exhaled nitric oxide,FeNO)재인동효천관리중적작용。방법선취미규범치료적효천환인60례(효천조)화동기40례건강인동(대조조)。효천조환인급여6개월적사미특라불체잡송기무제(Shah Mette Lo fluticasone propionate aerosol,상품명:서리질,50μg/100μg,bid)치료,검측치료전급치료후6개월적 FeNO、혈청기산양리자단백(eosinophile cationic protein,ECP)、혈청총면역구단백 E (total serum immunoglobulin E,IgE)급폐공능지표 FEVl점예계치백분비(FEVl%)。결과치료전,효천조 Fe-NO、ECP급 IgE균명현고우대조조(균P<0.01),FEVl%명현저우대조조(P<0.01)。여치료전비교:효천조치료6개월후적 FeNO、ECP급 IgE현저강저(균P<0.01),단잉고우대조조(균P<0.01);FEVl%수평명현승고(P<0.01),단여대조조비교차이무통계학의의(P>0.05)。치료전효천조 FeNO여혈청 ECP、IgE정정상관(r=0.850,P=0.000;r=0.689,P=0.000),여 FEVl%무상관성(r=-0.216,P=0.097)。치료6개월후,FeNO잉여혈청 ECP정정상관(r=0.665,P=0.000),이여 FEVl%、IgE 무상관성(r=0.185,r=0.226;P>0.05)。결론FeNO시일충교이상적반영기도기산성염증적생물학지표,유조우평고효천적공제정황。
ABSTRACT:Objective To discuss the application of fractional exhaled nitric oxide(FeNO)in the management of childhood asthma.Methods Sixty asthmatic children without standard medication treat-ment were treated with Shah Mette Lo fluticasone propionate aerosol(Seretide,50μg/100μg,bid).In addition,40 healthy children were recruited as controls.The FeNO,serum eosinophil cationic pro-tein(ECP),total serum immunoglobulin E(IgE)and forced expiratory volume in one second(FE-Vl)percent predicted (FEVl%)were determined before and after treatment for 6 months.Results Compared with control group,levels of FeNO,ECP and IgE increased before and after treat-ment but FEVl% decreased before treatment in asthmatic group(P<0.01).After treatment for 6 months,levels of FeNO,ECP and IgE decreased but FEVl% increased in asthmatic group (P<0.01).There was no significant difference in FEVl% between the two groups after treatment (P>0.05).Before treatment,FeNO levels were positively correlated with ECP levels(r=0.850, P=0.000)and IgE levels(r=0.689,P=0.000),but were not correlated with FEVl%(r=-0.216,P=0.097)in children with asthma.After treatment for 6 months,FeNO levels were still positively correlated with ECP levels(r=0.665,P=0.000),but were not correlated with FE-Vl%、IgE(r=0.185,r=0.266;P<0.05)in children with asthma.Conclusion FeNO is an ideal biological indicator reflecting eosinophilic airway inflammation,which can help to assess the con-trol of asthma.